ArticleAdvances in therapy2019

Factors Associated with Improvements in Patient-Reported Outcomes During Mirabegron or Antimuscarinic Treatment of Overactive Bladder Syndrome: A Registry Study (PERSPECTIVE).

Kevin V Carlson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.